Delay in cardiology consultation after primary care physician referrals in heart failure: Clinical implications.
ambulatory healthcare
gender differences
heart failure
primary care referral
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
17 Oct 2024
17 Oct 2024
Historique:
revised:
05
09
2024
received:
12
04
2024
accepted:
12
09
2024
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
17
10
2024
Statut:
aheadofprint
Résumé
To investigate the association between the elapsed time to cardiology care following a primary care physician (PCP) referral and 1 year outcomes among patients with heart failure (HF). Data from electronic medical records at our institution encompassing all PCP referrals to cardiology consultation from 2010 to 2021 (N = 68 518) were analysed. Of these, 6379 patients had a prior diagnosis of HF. Using a Cox regression model for hospitalization and mortality outcomes, the association between delay time in cardiology care post-PCP referral and 1 year outcomes was examined, adjusting for age, gender and comorbidities. A significant increase in 1 year mortality rates with delayed cardiology care was observed for each day: all-cause (0.25%), cardiovascular (CV) (0.13%) and HF (0.11%). In multivariate analysis, continuous delay to consultation was independently associated with higher risk of all-cause [hazard ratio (HR): 1.02; 95% confidence interval (CI) (1.01-1.02); P < 0.01], CV [1.01 (1.00-1.02); P < 0.01] and HF mortality (HR: 1.01; 95% CI 1.00-1.03; P < 0.01). Patients attended in the 25th quartile of time delay (<2 days) had significantly lower mortality and HF readmission rates [1.21 (1.10-1.33); P < 0.01] as compared with patients in the 75th quartile (>14 days). Delay in cardiology assistance following a PCP referral among patients previously diagnosed with HF was associated with increased in all-cause, CV, and HF mortality at 1 year.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Spanish Society of Cardiology
ID : SEC/FEC-INV-CLI 20/026
Organisme : Spanish Society of Cardiology
ID : SEC/FEC-INV-CLI 20/026)
Informations de copyright
© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Garcia‐Vega D, Mazón‐Ramos P, Portela‐Romero M, Rodríguez‐Mañero M, Rey‐Aldana D, Sestayo‐Fernández M, et al. Impact of a clinician‐to‐clinician electronic consultation in heart failure patients with previous hospital admissions. Eur Heart J Digit Health 2023;5:9‐20. doi:10.1093/ehjdh/ztad052
Nieuwenhuis MMW, Jaarsma T, Van VDJ, Van Der WMHL. Factors associated with patient delay in seeking care after worsening symptoms in heart failure patients. J Card Fail 2011;17:657‐663. doi:10.1016/j.cardfail.2011.04.004
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42:3599‐3726. doi:10.1093/eurheartj/ehab368
Saxena FE, Bierman AS, Glazier RH, Wang X, Guan J, Lee DS, et al. Association of early physician follow‐up with readmission among patients hospitalized for acute myocardial infarction, congestive heart failure, or chronic obstructive pulmonary disease. JAMA Netw Open 2022;5:e2222056. doi:10.1001/jamanetworkopen.2022.22056
Edmonston DL, Wu J, Matsouaka RA, Yancy C, Heidenreich P, Piña IL, et al. Association of post‐discharge specialty outpatient visits with readmissions and mortality in high‐risk heart failure patients. Am Heart J 2019;212:101‐112. doi:10.1016/j.ahj.2019.03.005
Seyed‐Nezhad M, Ahmadi B, Akbari‐Sari A. Factors affecting the successful implementation of the referral system: a scoping review. J Family Med Prim Care 2021;10:4364‐4375. doi:10.4103/jfmpc.jfmpc_514_21
Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:3232‐3245. doi:10.1093/eurheartj/ehw334
Suman S, Pravalika J, Manjula P, Farooq U. Gender and CVD—does it really matters? Curr Probl Cardiol 2023;101604. doi:10.1016/j.cpcardiol.2023.101604
Lala A, Tayal U, Hamo CE, Youmans Q, Al‐Khatib SM, Bozkurt B, et al. Sex differences in heart failure. J Card Fail 2022;28:477‐498. doi:10.1016/j.cardfail.2021.10.006
Rey‐Aldana D, Cinza‐Sanjurjo S, Portela‐Romero M, López‐Barreiro JL, Garcia‐Castelo A, Pazos‐Mareque JM, et al. Programa de consulta electrónica universal (e‐consulta) de un servicio de cardiología. Resultados a largo plazo. Rev Esp Cardiol 2022;75:159‐165. doi:10.1016/j.recesp.2020.11.007
Baecker A, Meyers M, Koyama S, Taitano M, Watson H, Machado M, et al. Evaluation of a transitional care program after hospitalization for heart failure in an integrated health care system. JAMA Netw Open 2020;3: doi:10.1001/jamanetworkopen.2020.27410
Al SA, Farahat R, Khatri AA. Effectiveness of transitional care interventions for heart failure patients: a systematic review with meta‐analysis. Cureus 2022;14:e29726. doi:10.7759/cureus.29726
Rohde LE, Rover MM, Filho CRH, Rabelo‐Silva ER, Silvestre OM, Martins SM, et al. Multifaceted strategy based on automated text messaging after a recent heart failure admission: the MESSAGE‐HF randomized clinical trial. JAMA Cardiol 2024;9:105‐113. doi:10.1001/JAMACARDIO.2023.4501
Lin CY, Hammash M, Miller JL, Schrader M, Mudd‐Martin G, Biddle MJ, et al. Delay in seeking medical care for worsening heart failure symptoms: predictors and association with cardiac events. Eur J Cardiovasc Nurs 2021;20:454‐463. doi:10.1093/eurjcn/zvaa032
Cotter G, Deniau B, Davison B, Edwards C, Adamo M, Arrigo M, et al. Optimization of evidence‐based heart failure medications after an acute heart failure admission: a secondary analysis of the STRONG‐HF randomized clinical trial. JAMA Cardiol 2024;9:114‐124. doi:10.1001/jamacardio.2023.4553
Adamo M, Pagnesi M, Mebazaa A, Davison B, Edwards C, Tomasoni D, et al. NT‐proBNP and high‐intensity care for acute heart failure: the STRONG‐HF trial. Eur Heart J 2023;44:2947‐2962. doi:10.1093/eurheartj/ehad335
Mebazaa A, Davison B, Chioncel O, Cohen‐Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up‐titration of guideline‐directed medical therapies for acute heart failure (STRONG‐HF): a multinational, open‐label, randomised, trial. Lancet 2022;400:1938‐1952. doi:10.1016/S0140‐6736(22)02076‐1
Averbuch T, Lee SF, Zagorski B, Mebazaa A, Fonarow GC, Thabane L, et al. Effect of a transitional care model following hospitalization for heart failure: 3‐year outcomes of the Patient‐Centered Care Transitions in Heart Failure (PACT‐HF) randomized controlled trial. Eur J Heart Fail 2024;26:652‐660. doi:10.1002/ejhf.3134
DeVore AD, Granger BB, Fonarow GC, Al‐Khalidi HR, Albert NM, Lewis EF, et al. Care optimization through patient and hospital engagement clinical trial for heart failure: rationale and design of CONNECT‐HF. Am Heart J 2020;220:41‐50. doi:10.1016/j.ahj.2019.09.012
Swat SA, Xu H, Allen LA, Greene SJ, DeVore AD, Matsouaka RA, et al. Opportunities and achievement of medication initiation among inpatients with heart failure with reduced ejection fraction. JACC Heart Fail 2023;11:918‐929. doi:10.1016/j.jchf.2023.04.015
Gullón P, Díez J, Cainzos‐Achirica M, Franco M, Bilal U. Social inequities in cardiovascular risk factors in women and men by autonomous regions in Spain. Gac Sanit 2021;35:326‐332. doi:10.1016/j.gaceta.2020.04.014
Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation 2018;137:e843‐e852. doi:10.1161/CIR.0000000000000582
Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet 2021;397:2385‐2438. doi:10.1016/S0140‐6736(21)00684‐X
Rosano GMC, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, et al. Gender differences in the effect of cardiovascular drugs: a position document of the working group on pharmacology and drug therapy of the ESC. Eur Heart J 2015;36:2677‐2680. doi:10.1093/eurheartj/ehv161
Vallabhajosyula S, Verghese D, Desai VK, Sundaragiri PR, Miller VM. Sex differences in acute cardiovascular care: a review and needs assessment. Cardiovasc Res 2022;118:667‐685. doi:10.1093/cvr/cvab063